Company Research Report: DrugBank

Company Overview

• Name: DrugBank

• Mission: To augment human intelligence so that everyone has access to the best possible medical outcomes.

• Founded: Created at the University of Alberta, no specific date provided.

• Founders: Initially developed by Craig Knox and Michael Wilson, under the guidance of Dr. David Wishart.

• Key People:

• Mike Wilson, CEO + Co-founder

• Martin Dawes, CEO of Genxys, as a notable partner

• Headquarters: Edmonton, Alberta, Canada.

• Number of Employees: No information is available.

• Revenue: No information is available.

• What the Company is Known For: DrugBank is renowned for being the world's most comprehensive, up-to-date pharmaceutical knowledge database. It leverages AI and machine learning to provide high-quality, machine learning-ready datasets.

Products

Clinical API

• Description: A tool that integrates with healthcare systems to enhance decision-making and improve patient care.

• Key Features:

• Plug and play API for seamless integration.

• Supports telehealth, electronic medical records, and other healthcare solutions.

Commercial Drug Datasets

• Description: Datasets tailored for business and commercial applications.

• Key Features:

• Machine-readable data that supports drug discovery and research.

• Includes biomedical knowledge, clinical trials, and therapeutic categories.

Academic Drug Datasets

• Description: Free and structured datasets designed for academic research.

• Key Features:

• Provides essential and supplementary data.

• Supports research with links to other sources and detailed documentation.

DrugBank Online

• Description: An online platform offering access to over 500,000 drug and drug product entries.

• Key Features:

• Searchable database with downloadable data.

• Partially free access for general use.

Recent Developments

• New Partnerships:

• Partnered with the American Society of Health-System Pharmacists (ASHP) to enhance the delivery of trusted data and explore product collaborations.

• Funding and Growth:

• Secured $9 million CAD in seed financing led by Brightspark Ventures to expand AI capabilities.

• Expansion:

• Expanded geographical coverage to seven new regions to strengthen global influence.

• Awards:

• Recognized as the 5th best workplace in Canada.

• Winner of the $125,000 Startup TNT Investment Summit.

• Technological Developments:

• Reported advancements in AI for drug discovery and data-driven drug repurposing for COVID-19 treatments.

• Launched new products on platforms like the Snowflake Marketplace for enhanced data accessibility.

Additional Information

• Research and Citations:

• Over 26,500 citations in scientific publications.

• Significant investment in research utilizing DrugBank solutions, amounting to over $1.5 billion.

• Customer Impact:

• Services major pharma companies, poised as a critical resource in drug discovery for healthcare organizations worldwide.

Note: Employee number and specific revenue figures were not available in the data provided.